Darrell R. Abernethydra@usp.org
Darrell R. Abernethy, MD, PhD, is chief science officer at the US Pharmacopeia. |
Heparin Monographs Further Revised
March 2, 2009 By: Anita Y. Szajek
,
Tina S. Morris
,
William F. Koch
,
Darrell R. Abernethy
,
Roger L. Williams
USP's Stage 2 heparin monograph revisions address identification, potency, and impurities. |
USP Metals Testing: A Workshop Report
November 2, 2008 By: Stefan Schuber, PhD
,
Anthony J. DeStefano, PhD
,
Roger L. Williams
,
William F. Koch
,
Darrell R. Abernethy
Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients. |
Inside USP: Metrology and USP Dissolution
March 2, 2008 By: Thomas S. Foster
,
Darrell R. Abernethy
,
William F. Koch
,
Walter W. Hauck, PhD
The United States Pharmacopeia emphasizes mechanical calibration and a performance test to esnure integrity of the dissolution procedure. |
Annual Scientific Meeting Recap
November 2, 2007 By: Roger L. Williams
,
Darrell R. Abernethy
Representatives from 17 nations sit down to decide upon standards-setting initiatives. |
|